Kroeger, Nicolaus; Wulf, Gerald; Hegenbart, Ute et al.
Autologous-allogeneic versus autologous tandem stem cell transplantation and maintenance therapy with thalidomide for multiple myeloma patients under 60 years of age: a prospective, phase II studyHAEMATOLOGICA. Bd. 109. H. 5. 2024 S. 1469-1479
Tölle, D; Reinholz, U
Begleitung in der Sterbephase - wertvolle Tipps für die Praxis [Care for the dying]MMW Fortschr Med. Bd. 166. H. 20. 2024 S. 44-47
Kriegsmann, Katharina; Ton, Gigi Nu Hoang Quy; Awwad, Mohamed H. S. et al.
CD8<SUP>+</SUP> CD28<SUP>-</SUP> regulatory T cells after induction therapy predict progression-free survival in myeloma patients: results from the GMMG-HD6 multicenter phase III studyLEUKEMIA. Bd. 38. H. 7. 2024 S. 1621-1625
Novak, Urban; Mooyaart, Jarl E.; Daskalakis, Michael et al.
Choice of commercially available CAR-T cell products for r/r DLBCL & PMBCL in Europe: a survey on behalf of the cellular therapy & immunobiology working party (CTIWP) of the EBMTBONE MARROW TRANSPLANTATION. Bd. 59. H. 11. 2024 S. 1631-1634
Winter, Susann; Goetze, Katharina S.; Hecker, Judith S. et al.
Clonal hematopoiesis and its impact on the aging osteo-hematopoietic nicheLEUKEMIA. Bd. 38. H. 5. 2024 S. 936-946
Duque-Afonso, Jesus; Finke, Juergen; Ngoya, Maud et al.
Comparison of fludarabine/melphalan (FM140) with fludarabine/melphalan/BCNU (FBM110) in patients with relapsed/refractory AML undergoing allogeneic hematopoietic cell transplantation - a registry study on behalf of the EBMT Acute Leukemia Working PartyBONE MARROW TRANSPLANTATION. 2024
Salwender, Hans; Weinhold, Niels; Benner, Axel et al.
Cytomegalovirus immunoglobulin serology prevalence in patients with newly diagnosed multiple myeloma treated within the GMMG-MM5 phase III trialHEMATOLOGY. Bd. 29. H. 1. 2024
Buchwaldt, Jessika; Fritsch, Tania; Hartmann, Monika et al.
Decreased mitochondrial transcription factor A and mitochondrial DNA copy number promote cyclin-dependent kinase inhibitor 1A expression and reduce tumorigenic properties of colorectal cancer cellsDISCOVER ONCOLOGY. Bd. 15. H. 1. 2024
Schönefeld, A; Zanetti, C; Schmitt, E et al.
DNMT/G9a Complex Inhibition Uncovers Epigenetic Vulnerabilities and Induces IFN-Response in Acute Myeloid LeukemiabioRxiv. 2024 S. 1-23
Al Hariri, Mohammad; Munder, Markus; Pfeiffer, Norbert et al.
Does Systemic Hematological Therapy Influence the Course of Paraproteinemic Keratopathy?JOURNAL OF CLINICAL MEDICINE. Bd. 13. H. 2. 2024